Scout | Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)

This grant opportunity aims to support research focusing on two main areas related to HIV and substance use disorder (SUD). Firstly, it seeks to identify targets and pathways to suppress HIV activity in the body, especially in the central nervous system of individuals with SUD. Secondly, it encourages the development of new small molecule drugs that can be used to suppress HIV transcription in…

Source

Agency: National Institutes of Health

Program: SBIR

Award

Award Ceiling: $400,000

Funding Amount: $400,000

Dates

Opportunity Released: December 20, 2023

Open for Submission: December 20, 2023

Submission Deadline: August 13, 2024

Application Window Closes: August 13, 2024

Keywords

HIV

substance use disorders

HIV transcription

chemical probes

drug discovery

pharmacological probes

neuropathological complications

viral latency

small molecule compounds

CNS reservoirs

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers